BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28166057)

  • 1. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):444-453. PubMed ID: 26907917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.
    Wang Y; Efstathiou JA; Sharp GC; Lu HM; Ciernik IF; Trofimov AV
    Med Phys; 2011 Aug; 38(8):4623-33. PubMed ID: 21928635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
    Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
    Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
    Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
    Bridges D; Kawamura H; Kanai T
    PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
    Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
    Liu F; Ahunbay E; Lawton C; Li XA
    Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
    Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
    Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
    Goddard LC; Brodin NP; Bodner WR; Garg MK; Tomé WA
    Br J Radiol; 2018 May; 91(1085):20180010. PubMed ID: 29436852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
    Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
    Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
    Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of organ motion on proton prostate treatments, as determined from analysis of daily CT imaging for patient positioning.
    Maeda Y; Sato Y; Shibata S; Bou S; Yamamoto K; Tamamura H; Fuwa N; Takamatsu S; Sasaki M; Tameshige Y; Kume K; Minami H; Saga Y; Saito M
    Med Phys; 2018 May; 45(5):1844-1856. PubMed ID: 29574901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.